Mycenax Biotech Inc.

Industry

  • Pharmaceuticals
    • Generic Drugs
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Contract Manufacturing Organization
  • Contract Research Organization-CRO
See more in Biomedtracker

Latest on Mycenax Biotech Inc.

Generics Bulletin

Gedeon Richter Teases Denosumab Partnering Opportunity In Japan

 
• By Urtė Fultinavičiūtė

Hungary’s Gedeon Richter is on a lookout for a potential partner to bring its denosumab biosimilar to the Japanese market, teased CEO Gábor Orbán during the firm’s Q1 2024 earnings call. “The Japane

Scrip

Roche’s Actemra Scores New Indication In Rare Autoimmune Disease

 
• By Alaric DeArment

Roche Holding AG ’s Actemra (tocilizumab) has received its latest in a string of US Food and Drug Administration approvals, for interstitial lung disease associated with systemic sclerosis (SSc-ILD),